Wingspan announces that its eTMF for Official electronic Trial Master File has been selected by Europe's largest biopharmaceutical company

Wingspan announces that its eTMF for Official electronic Trial Master File has been selected by Europe's largest biopharmaceutical company

November 11, 2013

BLUE BELL, Pa.--(BUSINESS WIRE)--Wingspan announces that Actelion Pharmaceuticals, a top 20 biopharmaceutical company, has selected Wingspan eTMF as its official electronic trial master file. The company, based in Switzerland, outlined specific goals of the trial master file implementation including providing key management metrics, increasing inspection readiness, saving time, reducing costs and increasing eTMF quality. Wingspan eTMF allows Actelion access to comprehensive metrics and reports in real time and integrates with the company's existing applications. Because Wingspan eTMF is cloud-based, Actelion's clinical trial specialists will have 24-hour access to trial related documents managed by Wingspan eTMF and easy external access from any location for all users, including CROs and partners.

Additionally, Actelion selected Wingspan given the technology company's specialized focus on eTMF and strong client references from Pfizer and ICON, plc.

Wingspan Principal and CEO, Troy Deck said, "We are thrilled to have Actelion as a client and extraordinarily excited to be able to support their worldwide research through the use of our eTMF platform. Wingspan's technical excellence and focus on trial efficiency aligns well with Actelion's core values of Innovation and Results-Driven approach. Working together, we will continue to shape and improve the TMF landscape through refinement and expansion of our powerful and distinct capabilities."

After signing contractual agreements last week, Wingspan project managers joined the Actelion team in Switzerland to kick-off the implementation project. Wingspan will work with Actelion to launch its pilot project in mid-February with a larger rollout in June.

About Actelion Pharmaceuticals

Actelion is a biopharmaceutical company focused on the discovery, development and commercialization of small molecule drugs as innovative treatments to serve high unmet medical needs. The company has its corporate headquarters in Allschwil/Basel, Switzerland where it was founded in 1997. The company has proven its ability to discover new compounds and to rapidly move them from research through development to commercialization. In particular, Actelion scientists were among the first to work in the field of endothelin receptor antagonists.

About Wingspan Technology, Inc.

Wingspan Technology, Inc. is the leading provider of life sciences and eClinical software solutions, including Wingspan eTMF and DocWay, the SharePoint/Documentum integration product suite. Wingspan's talented and knowledgeable engineering and project management teams offer in-depth industry knowledge and experience to companies in life sciences, pharmaceutical, financial services, and other fields.

Contacts

Wingspan Technology, Inc.
Meghan McKeown
Sales and Marketing Associate
610-941-6500
Fax 866-398-7398
[email protected]
www.wingspan.com

 

Suggested Articles

There's no evidence personal patient information leaked during the 11-week breach, but the same can't be said about Sangamo's own secrets.

Through a new online tracker, AllTrials names sponsors who fail to report clinical trial results on time per the FDAAA Final Rule.

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.